CN114504528A - 一种靶向祛斑美白的面霜 - Google Patents
一种靶向祛斑美白的面霜 Download PDFInfo
- Publication number
- CN114504528A CN114504528A CN202011567202.6A CN202011567202A CN114504528A CN 114504528 A CN114504528 A CN 114504528A CN 202011567202 A CN202011567202 A CN 202011567202A CN 114504528 A CN114504528 A CN 114504528A
- Authority
- CN
- China
- Prior art keywords
- mixture
- parts
- phase
- cream
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 31
- 230000002087 whitening effect Effects 0.000 title claims abstract description 17
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 20
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 15
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 15
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 12
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 11
- 229960001631 carbomer Drugs 0.000 claims abstract description 11
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000230 xanthan gum Substances 0.000 claims abstract description 11
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 11
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 11
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 11
- 239000004475 Arginine Substances 0.000 claims abstract description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 8
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 claims abstract description 7
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 7
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 7
- 229960000458 allantoin Drugs 0.000 claims abstract description 7
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 7
- 229940117973 dimethylmethoxy chromanol Drugs 0.000 claims abstract description 7
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940099563 lactobionic acid Drugs 0.000 claims abstract description 7
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 7
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 7
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 claims abstract description 6
- JXPHIHWXMBYJAU-UHFFFAOYSA-N 7-methoxy-2,2-dimethyl-3,4-dihydrochromen-6-ol Chemical compound O1C(C)(C)CCC2=C1C=C(OC)C(O)=C2 JXPHIHWXMBYJAU-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims description 22
- 238000001816 cooling Methods 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 13
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 12
- 230000001804 emulsifying effect Effects 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 229960005323 phenoxyethanol Drugs 0.000 claims description 9
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 6
- 229960003993 chlorphenesin Drugs 0.000 claims description 6
- 230000008685 targeting Effects 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 claims description 3
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 241000501743 Gentiana macrophylla Species 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 230000007815 allergy Effects 0.000 claims description 3
- 239000008168 almond oil Substances 0.000 claims description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 3
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 claims description 3
- 229940006284 undaria pinnatifida extract Drugs 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 2
- 241000967294 Swertia japonica Species 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 9
- 210000003491 skin Anatomy 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229940081733 cetearyl alcohol Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000009965 odorless effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 206010003671 Atrioventricular Block Diseases 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 2
- 208000002141 Pellagra Diseases 0.000 description 2
- 206010040639 Sick sinus syndrome Diseases 0.000 description 2
- 241000589636 Xanthomonas campestris Species 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000020939 nutritional additive Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 229940069762 swertia japonica extract Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Abstract
一种靶向祛斑美白的面霜，属于面霜护理配方领域，主要原料包括A相混合物、B相混合物、C相混合物、D相混合物和植物舒敏剂及香精，其中，所述A相混合物由M68乳化剂、鲸蜡硬脂醇、A165乳化剂、环五聚二甲基硅氧烷、聚二甲基硅氧烷、二甲基甲氧基苯并二氢吡喃醇、棕榈酸乙基己酯、1,2‑戊二醇和KN‑K206‑T混合物组成，所述B相混合物由纯水、甘油、EDTA二钠、丁二醇、尿囊素、烟酰胺、a‑熊果苷、黄原胶、卡波姆和乳糖酸组成。本发明提供的面霜的成分多为乳液脂类和植物提取物，其本身通过KN‑K206‑T混合物等诸多天然抗氧化的成分为还添加了抑黑美白成分，同时还有皮肤易吸收的精氨酸等促进皮肤细胞活力的因子，祛斑效果显著，天然无刺激，效果更佳。
Description
技术领域
本发明属于面霜配方领域，具体涉及一种靶向祛斑美白的面霜。
背景技术
面霜、乳液是基础护肤最重要的一步了，面霜、乳液中的美白、抗衰老等有效成分能够更好的被肌肤吸收，提供双重抗老化作用，可刺激细胞新生能量，同时促进胶原蛋白合成，改善肌肤表层的纹理与肤色均匀度，使肌肤更细致，同时含有可提供SPF15的滤光系统与可保护肌肤对抗环境污染的辣木精华，保持肌肤不受光的直接伤害；
市面上出现了一种修颜的面霜/乳液，俗称“七天霜”，它一般呈霜剂和乳液状态，大多添加了化妆品成份，涂上有相对的修饰面色和遮盖印痕的效果，但是其本身含有刺激性的化妆品成分，长时间也对毛孔的吸收造成堵塞，不利于吸收。
发明内容
为克服现有技术所存在的缺陷，本发明提供一种靶向祛斑美白的面霜及其生产方法，能够解决上述技术问题。
本发明要解决其技术问题所采用的技术方案是：设计一种靶向祛斑美白的面霜，主要原料包括A相混合物、B相混合物、C相混合物、D相混合物和植物舒敏剂及香精，其中，
所述A相混合物由M68乳化剂、鲸蜡硬脂醇、A165乳化剂、环五聚二甲基硅氧烷、聚二甲基硅氧烷、二甲基甲氧基苯并二氢吡喃醇、棕榈酸乙基己酯、1,2-戊二醇和KN-K206-T混合物组成；
所述B相混合物由纯水、甘油、EDTA 二钠、丁二醇、尿囊素、烟酰胺、a-熊果苷、黄原胶、卡波姆和乳糖酸组成；
所述C相混合物由精氨酸和纯水组成；
所述D相混合物由丁二醇、对羟基苯乙酮、氯苯甘醚和苯氧乙醇组成。
进一步的，所述A相混合物的消耗量（质量份数）为：
M68乳化剂 15份
鲸蜡硬脂醇 20份
A165乳化剂 12份
环五聚二甲基硅氧烷 15份
聚二甲基硅氧烷 10份
二甲基甲氧基苯并二氢吡喃醇 12份
棕榈酸乙基己酯 10份
1,2-戊二醇 15份
KN-K206-T混合物 10份；
所述B相混合物的消耗量（质量份数）为：
纯水 680份
甘油 50份
EDTA二钠 0.5份
丁二醇 30份
尿囊素 2份
烟酰胺 20份
a-熊果苷 5份
黄原胶 1份
卡波姆 3.5份
乳糖酸 0.7份；
所述C相混合物的消耗量（质量份数）为：
精氨酸 0.7份
纯水 20份；
所述D相混合物的消耗量（质量份数）为：
丁二醇 30份
对羟基苯乙酮 5份
氯苯甘醚 1.5份
苯氧乙醇 1.5份；
剩余原料消耗量（质量份数）为：
植物舒敏剂 30份
香精 0.03份。
进一步的，所述A相混合物中的KN-K206-T混合物由蔗糖棕榈酸酯、丁二醇、甘油亚油酸酯、甜扁桃油、光果甘草根提取物、抗坏血酸磷酸酯镁、裙带菜提取物、苯氧乙醇组成。
进一步的，所述植物舒敏剂由丙二醇、水、日本獐牙菜提取物、牡丹根提取物、秦艽提取物组成。
黄原胶(又名汉生胶，是由野油菜黄单胞杆菌 以碳水化合物为主要原料经发酵工程生产的一种作用广泛的微生物胞外多糖，它具有独特的流变性，良好的水溶性、对热及酸碱的稳定性、与多种盐类有很好的相容性，作为增稠剂、悬浮剂、乳化剂、稳定；
鲸蜡硬脂醇(和)鲸蜡硬脂基葡糖苷M68乳化剂性能结构，从谷物中提取的葡萄糖,从椰子油中提取的脂肪。独特性在于使用一种多糖取代作为传统非离子表面活性剂特征之一的乙氧基化基团.这样就得到一种由亲水糖苷和亲油的椰油链构成的产品；
烟酰胺又称尼克酰胺，是烟酸的酰胺化合物，为白色的结晶性粉末，无臭或几乎无臭，味苦，略有引湿性，在水或乙醇中易溶，在甘油中溶解，主要用于防治糙皮病、口炎、舌炎，病态窦房结综合征，房室传导阻滞等问题，在本发明中主要作为营养性添加剂；
鲸蜡硬脂醇具有抑制油腻感，降低蜡类原料黏性，稳定化妆品乳胶体等作用适用于各类化妆品中，作为基质，特别适合于膏霜及乳液；在医药中，可直接用于W/O乳化剂膏体，软膏基质等，也可用于消泡剂，水土保湿剂，成色剂；还可作为生产醇，酰胺及磺化产品作洗涤剂用品原料；
卡波也称卡波姆，是以季戊四醇等与丙烯酸交联得到的丙烯酸交联树脂，是一类非常重要的流变调节剂，中和后的卡波是优秀的凝胶基质，有增稠、悬浮等重要用途，工艺简单，稳定性好，广泛应用于乳液、膏霜、凝胶中。
进一步的，制备方法如下：
（1）将A相混合物投入锅升温并搅拌至85℃保温待用；
（2）将B相混合物投入乳化锅搅拌升温至60℃均质至B相混合物完全溶解后继续升温至85℃；
（3）将A相混合物抽入乳化锅均质15分钟后保温静置15-20分钟；
（4）降温至60℃投入预先溶解的C相混合物并均质1分钟、搅拌至均匀；
（5）降温至45℃依次投入植物舒敏剂及香精继续搅拌至均匀；
（6）降温至40度投入D箱混合物并均质10分钟至均匀；
（7）温度降至38℃时取样检测，检测合格出料。
进一步的，步骤（4）-（7）中的降温方式为直接循环水降温和抽真空循环降温的一种，当所述乳化锅内原料无气泡时采用所述直接循环水降温，当所述乳化锅内原料有气泡时，则使用所述抽真空循环降温的方式。
本发明所具有的有益效果是：
本发明提供的靶向祛斑美白的面霜的成分多为乳液脂类和植物提取物，其本身通过KN-K206-T混合物等诸多天然抗氧化的成分为还添加了抑黑美白成分，同时还有皮肤易吸收的精氨酸等促进皮肤细胞活力的因子，祛斑效果显著，天然无刺激，效果更佳。
具体实施方式
一种靶向祛斑美白的面霜，主要原料包括A相混合物、B相混合物、C相混合物、D相混合物和植物舒敏剂及香精，其中，
所述A相混合物由M68乳化剂、鲸蜡硬脂醇、A165乳化剂、环五聚二甲基硅氧烷、聚二甲基硅氧烷、二甲基甲氧基苯并二氢吡喃醇、棕榈酸乙基己酯、1,2-戊二醇和KN-K206-T混合物组成；
所述B相混合物由纯水、甘油、EDTA 二钠、丁二醇、尿囊素、烟酰胺、a-熊果苷、黄原胶、卡波姆和乳糖酸组成；
所述C相混合物由精氨酸和纯水组成；
所述D相混合物由丁二醇、对羟基苯乙酮、氯苯甘醚和苯氧乙醇组成。
在本实施例中，所述A相混合物的消耗量（质量份数）为：
M68乳化剂 15份
鲸蜡硬脂醇 20份
A165乳化剂 12份
环五聚二甲基硅氧烷 15份
聚二甲基硅氧烷 10份
二甲基甲氧基苯并二氢吡喃醇 12份
棕榈酸乙基己酯 10份
1,2-戊二醇 15份
KN-K206-T混合物 10份；
所述B相混合物的消耗量（质量份数）为：
纯水 680份
甘油 50份
EDTA二钠 0.5份
丁二醇 30份
尿囊素 2份
烟酰胺 20份
b-熊果苷 5份
黄原胶 1份
卡波姆 3.5份
乳糖酸 0.7份；
所述C相混合物的消耗量（质量份数）为：
精氨酸 0.7份
纯水 20份；
所述D相混合物的消耗量（质量份数）为：
丁二醇 30份
对羟基苯乙酮 5份
氯苯甘醚 1.5份
苯氧乙醇 1.5份；
剩余原料消耗量（质量份数）为：
植物舒敏剂 30份
香精 0.03份。
在本实施例中，所述A相混合物中的KN-K206-T混合物由蔗糖棕榈酸酯、丁二醇、甘油亚油酸酯、甜扁桃油、光果甘草根提取物、抗坏血酸磷酸酯镁、裙带菜提取物、苯氧乙醇组成。
在本实施例中，所述植物舒敏剂由丙二醇、水、日本獐牙菜提取物、牡丹根提取物、秦艽提取物组成。
黄原胶(又名汉生胶，是由野油菜黄单胞杆菌 以碳水化合物为主要原料经发酵工程生产的一种作用广泛的微生物胞外多糖，它具有独特的流变性，良好的水溶性、对热及酸碱的稳定性、与多种盐类有很好的相容性，作为增稠剂、悬浮剂、乳化剂、稳定；
鲸蜡硬脂醇(和)鲸蜡硬脂基葡糖苷M68乳化剂性能结构，从谷物中提取的葡萄糖,从椰子油中提取的脂肪，独特性在于使用一种多糖取代作为传统非离子表面活性剂特征之一的乙氧基化基团.这样就得到一种由亲水糖苷和亲油的椰油链构成的产品；
烟酰胺又称尼克酰胺，是烟酸的酰胺化合物，为白色的结晶性粉末，无臭或几乎无臭，味苦，略有引湿性，在水或乙醇中易溶，在甘油中溶解，主要用于防治糙皮病、口炎、舌炎，病态窦房结综合征，房室传导阻滞等问题，在本发明中主要作为营养性添加剂；
鲸蜡硬脂醇具有抑制油腻感，降低蜡类原料黏性，稳定化妆品乳胶体等作用适用于各类化妆品中，作为基质，特别适合于膏霜及乳液；在医药中，可直接用于W/O乳化剂膏体，软膏基质等，也可用于消泡剂，水土保湿剂，成色剂；还可作为生产醇，酰胺及磺化产品作洗涤剂用品原料；
卡波也称卡波姆，是以季戊四醇等与丙烯酸交联得到的丙烯酸交联树脂，是一类非常重要的流变调节剂，中和后的卡波是优秀的凝胶基质，有增稠、悬浮等重要用途，工艺简单，稳定性好，广泛应用于乳液、膏霜、凝胶中
在本实施例中，制备方法如下：
预备阶段
清洗锅具消毒待用、将预先溶解的桶、勺子、过滤布、出料口等预先消毒用前二次消毒。
制备阶段
将A相原料投入锅升温〈间接点动搅拌〉至85℃保温待用；
将B相原料投入乳化锅搅拌〈速25转每秒〉升温至60℃均质至B相原料完全溶解继续升温至85℃；
将A相原料抽入乳化锅均质15分钟保温15-20分钟；
开启循环水降温〈如有可泡抽真空降温〉，降温至60℃〈如有抽真空先开滤阀后可开升降〉投入预先溶解的C相原料、搅拌〈速25转每秒〉至均匀；
继续降温至45℃投入植物舒敏剂和香精搅拌〈速20转每秒〉均匀；
降温至40℃依次投入D相原料继续搅拌至均匀；
.温度降至38℃时〈取样后搅拌3分可关搅拌器〉检测合格出料〈注意出料前消毒如：手、乳化锅、桶、等〉。
最后所应说明的是：以上实施例仅用以说明而非限制本发明的技术方案，尽管参照上述实施例对本发明进行了详细说明，本领域的普通技术人员应该理解：依然可以对本发明进行修改或者等同替换，而不脱离本发明的精神和范围的任何修改或局部替换，其均应涵盖在本发明的权利要求范围当中。
Claims (6)
1.一种靶向祛斑美白的面霜，其特征在于，主要原料包括A相混合物、B相混合物、C相混合物、D相混合物和植物舒敏剂及香精，其中，
所述A相混合物由M68乳化剂、鲸蜡硬脂醇、A165乳化剂、环五聚二甲基硅氧烷、聚二甲基硅氧烷、二甲基甲氧基苯并二氢吡喃醇、棕榈酸乙基己酯、1,2-戊二醇和KN-K206-T混合物组成；
所述B相混合物由纯水、甘油、EDTA 二钠、丁二醇、尿囊素、烟酰胺、a-熊果苷、黄原胶、卡波姆和乳糖酸组成；
所述C相混合物由精氨酸和纯水组成；
所述D相混合物由丁二醇、对羟基苯乙酮、氯苯甘醚和苯氧乙醇组成。
2.根据权利要求1所述的一种靶向祛斑美白的面霜，其特征在于，
所述A相混合物的消耗量（质量份数）为：
M68乳化剂 15份
鲸蜡硬脂醇 20份
A165乳化剂 12份
环五聚二甲基硅氧烷 15份
聚二甲基硅氧烷 10份
二甲基甲氧基苯并二氢吡喃醇 12份
棕榈酸乙基己酯 10份
1,2-戊二醇 15份
KN-K206-T混合物 10份；
所述B相混合物的消耗量（质量份数）为：
纯水 680份
甘油 50份
EDTA二钠 0.5份
丁二醇 30份
尿囊素 2份
烟酰胺 20份
a-熊果苷 5份
黄原胶 1份
卡波姆 3.5份
乳糖酸 0.7份；
所述C相混合物的消耗量（质量份数）为：
精氨酸 0.7份
纯水 20份；
所述D相混合物的消耗量（质量份数）为：
丁二醇 30份
对羟基苯乙酮 5份
氯苯甘醚 1.5份
苯氧乙醇 1.5份；
剩余原料消耗量（质量份数）为：
植物舒敏剂 30份
香精 0.03份。
3.根据权利要求2所述的一种靶向祛斑美白的面霜，其特征在于：所述A相混合物中的KN-K206-T混合物由蔗糖棕榈酸酯、丁二醇、甘油亚油酸酯、甜扁桃油、光果甘草根提取物、抗坏血酸磷酸酯镁、裙带菜提取物、苯氧乙醇组成。
4.根据权利要求2所述的一种靶向祛斑美白的面霜，其特征在于：所述植物舒敏剂由丙二醇、水、日本獐牙菜提取物、牡丹根提取物、秦艽提取物组成。
5.根据权利要求2所述的一种靶向祛斑美白的面霜，其特征在于，制备方法如下：
（1）将A相混合物投入锅升温并搅拌至85℃保温待用；
（2）将B相混合物投入乳化锅搅拌升温至60℃均质至B相混合物完全溶解后继续升温至85℃；
（3）将A相混合物抽入乳化锅均质15分钟后保温静置15-20分钟；
（4）降温至60℃投入预先溶解的C相混合物并均质1分钟、搅拌至均匀；
（5）降温至45℃依次投入植物舒敏剂及香精继续搅拌至均匀；
（6）降温至40度投入D箱混合物并均质10分钟至均匀；
（7）温度降至38℃时取样检测，检测合格出料。
6.根据权利要求5所述的一种靶向祛斑美白的面霜制备方法，其特征在于：步骤（4）-（7）中的降温方式为直接循环水降温和抽真空循环降温的一种，当所述乳化锅内原料无气泡时采用所述直接循环水降温，当所述乳化锅内原料有气泡时，则使用所述抽真空循环降温的方式。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011567202.6A CN114504528A (zh) | 2020-12-25 | 2020-12-25 | 一种靶向祛斑美白的面霜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011567202.6A CN114504528A (zh) | 2020-12-25 | 2020-12-25 | 一种靶向祛斑美白的面霜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114504528A true CN114504528A (zh) | 2022-05-17 |
Family
ID=81547030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011567202.6A Pending CN114504528A (zh) | 2020-12-25 | 2020-12-25 | 一种靶向祛斑美白的面霜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114504528A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108553365A (zh) * | 2018-06-01 | 2018-09-21 | 广州锦同生物科技有限公司 | 一种苹果肌丝滑面膜及其制备方法 |
| CN110279598A (zh) * | 2019-07-09 | 2019-09-27 | 许富明 | 一种美白祛斑霜制备方法 |
| CN111067838A (zh) * | 2020-01-15 | 2020-04-28 | 广州市逸轩精细化工有限公司 | 一种美白祛斑组合物，美白祛斑霜及其制备方法 |
-
2020
- 2020-12-25 CN CN202011567202.6A patent/CN114504528A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108553365A (zh) * | 2018-06-01 | 2018-09-21 | 广州锦同生物科技有限公司 | 一种苹果肌丝滑面膜及其制备方法 |
| CN110279598A (zh) * | 2019-07-09 | 2019-09-27 | 许富明 | 一种美白祛斑霜制备方法 |
| CN111067838A (zh) * | 2020-01-15 | 2020-04-28 | 广州市逸轩精细化工有限公司 | 一种美白祛斑组合物，美白祛斑霜及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107802543B (zh) | 一种刺梨素焕肤生物纤维面膜及其制备方法 | |
| CN103599007A (zh) | 含有芦荟汁的化妆水及其制备方法 | |
| CN112402347A (zh) | 一种含纤连蛋白的祛痘修复组合物及其制备方法 | |
| CN108403522A (zh) | 一种基于植物花提取物的四季系列化妆水 | |
| CN105707795A (zh) | 一种脱苦天然玫瑰花渣浸膏及其制备方法和用途 | |
| CN107875092A (zh) | 一种晒后修复精华液及其制备方法 | |
| KR20140048700A (ko) | 검버섯 및 잔주름 개선기능을 갖는 생약숙성탕액을 이용한 천연비누 및 그 제조방법 | |
| WO2018112857A1 (zh) | 一种补水护肤乳液 | |
| CN103462855B (zh) | 一种含有西洋参和桂圆的化妆品及其制备方法 | |
| CN113041201A (zh) | 抚纹眼霜 | |
| CN104055706A (zh) | 去红血丝化妆品组合物及其制备方法 | |
| CN114504528A (zh) | 一种靶向祛斑美白的面霜 | |
| CN108078827B (zh) | 一种止脱生发洗发水及其制备方法 | |
| CN112402328B (zh) | 一种淡化细纹补水提亮的茶多酚亮颜精华油及其生产工艺 | |
| CN106361595A (zh) | 一种智妍导入溶媒精华液 | |
| CN113786371A (zh) | 一种制备越橘海藻面膜的组合物、面膜及制备方法 | |
| WO2018112858A1 (zh) | 一种植物提取物乳液 | |
| CN105232376A (zh) | 江蓠海藻美容面膜 | |
| CN109125242A (zh) | 一种修复痘印的外用剂及其制备方法 | |
| CN112656742A (zh) | 一种葡萄籽红酒面膜泥及其制备方法 | |
| JP2005179219A (ja) | 皮膚外用剤 | |
| CN104257566A (zh) | 一种具有调理作用的化妆品用组合物及其应用 | |
| AU2020102418A4 (en) | Individually packaged lycium ruthenicum murr. anthocyanin facial mask | |
| CN115919698B (zh) | 一种紧致抗皱功效组合物及其应用 | |
| KR102657593B1 (ko) | 톳 추출물을 유효성분으로 함유하는 필라그린 활성이 우수한 피부장벽 강화 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |